Elutia Inc (NAS:ELUT)
$ 3.3602 0.0502 (1.52%) Market Cap: 81.82 Mil Enterprise Value: 90.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Q3 2022 Aziyo Biologics Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $8.1 (+1.12%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Aziyo Biologics Third Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference call over to Matt Steinberg, Fin Partners. Sir, the floor is yours.

Matt Steinberg;Finn Partners;Vice President

Thank you, operator, and thank you all for participating in today's call. Earlier today, Aziyo released financial results for the quarter ended September 30, 2022. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that do not relate to matters of historical facts or relate to expectations or predictions of future events,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot